CEO, The Global Alliance for Genomics and Health
Peter Goodhand is a senior executive and board member in the health research advancement community. Starting in the UK in 1980 and moving to North America in 1986, Goodhand had a 20-year career in the global medical technology industry, including international leadership roles with American Cyanamid and Johnson & Johnson. In 2003 he became the Founding Managing Director of the Health Technology Exchange (HTX) and the Chairman of the Board in 2004. He then spent 8 years at the Canadian Cancer Society, as a President and CEO before presiding the Ontario Institute for Cancer Research for 2 additional years. He is now the CEO of The Global Alliance for Genomics and Health.